These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 16181208)

  • 1. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary anti-D immunization by DEL red blood cells.
    Kim KH; Kim KE; Woo KS; Han JY; Kim JM; Park KU
    Korean J Lab Med; 2009 Aug; 29(4):361-5. PubMed ID: 19726900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-D immunization by DEL red blood cells.
    Wagner T; Körmöczi GF; Buchta C; Vadon M; Lanzer G; Mayr WR; Legler TJ
    Transfusion; 2005 Apr; 45(4):520-6. PubMed ID: 15819672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.
    Körmöczi GF; Gassner C; Shao CP; Uchikawa M; Legler TJ
    Transfusion; 2005 Oct; 45(10):1561-7. PubMed ID: 16181205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria.
    Polin H; Danzer M; Gaszner W; Broda D; St-Louis M; Pröll J; Hofer K; Gabriel C
    Transfusion; 2009 Apr; 49(4):676-81. PubMed ID: 19170995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients?
    Krog GR; Clausen FB; Berkowicz A; Jørgensen L; Rieneck K; Nielsen LK; Dziegiel MH
    Transfusion; 2011 Nov; 51(11):2278-85. PubMed ID: 21569040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors.
    Luettringhaus TA; Cho D; Ryang DW; Flegel WA
    Transfusion; 2006 Dec; 46(12):2128-37. PubMed ID: 17176325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of real time PCR for rapid detection of Del phenotype in Taiwan.
    Sun CF; Liu JP; Chen DP; Wang WT; Yang TT
    Ann Clin Lab Sci; 2008; 38(3):258-63. PubMed ID: 18715855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
    Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
    Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHD 1227A is an important genetic marker for RhD(el) individuals.
    Chen JC; Lin TM; Chen YL; Wang YH; Jin YT; Yue CT
    Am J Clin Pathol; 2004 Aug; 122(2):193-8. PubMed ID: 15323135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular genetics of RH and its clinical application.
    Flegel WA
    Transfus Clin Biol; 2006; 13(1-2):4-12. PubMed ID: 16563832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density.
    Mota M; Fonseca NL; Rodrigues A; Kutner JM; Castilho L
    Vox Sang; 2005 Feb; 88(2):130-5. PubMed ID: 15720611
    [No Abstract]   [Full Text] [Related]  

  • 17. The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes.
    Scott SA; Nagl L; Tilley L; Liew YW; Condon J; Flower R; Hyland CA
    Transfusion; 2014 Nov; 54(11):2931-40. PubMed ID: 24894016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased immunorejection in unmatched blood transfusions by attachment of methoxypolyethylene glycol on human red blood cells and the effect on D antigen.
    Tan Y; Qiu Y; Xu H; Ji S; Li S; Gong F; Zhang Y
    Transfusion; 2006 Dec; 46(12):2122-7. PubMed ID: 17176324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A RhD negative patient failed to produce detectable anti-D after transfusion of 35 units of RhD positive red blood cells].
    Lee WM; Kim JH; Ha JS; Ryoo NH; Jeon DS; Kim JR; Cho D
    Korean J Lab Med; 2007 Oct; 27(5):369-72. PubMed ID: 18094603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloanti-c/ce in a c+ceAR/Ce patient suggests that the rare RHCE ceAR allele (ceAR) encodes a partial c antigen.
    Peyrard T; Pham BN; Poupel S; Martin-Blanc S; Auxerre C; Kappler-Gratias S; Bonin P; Rouger P; Le Pennec PY
    Transfusion; 2009 Nov; 49(11):2406-11. PubMed ID: 19624489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.